Chronic stable angina: Difference between revisions
No edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
==[[Chronic stable angina treatment|Treatment]]== | ==[[Chronic stable angina treatment|Treatment]]== | ||
''' | '''[[Chronic stable angina risk factor modifications|Risk factor modifications]]:''' [[Chronic stable angina treatment smoking cessation|Smoking cessation]] | [[Chronic stable angina treatment weight management|Weight management]] | [[Chronic stable angina treatment physical activity|Physical activity]] | [[Chronic stable angina treatment lipid management|Lipid management]] | [[Chronic stable angina treatment blood pressure control|BP control]] | [[Chronic stable angina treatment diabetes control|Diabetes control]] | [[Chronic stable angina treatment ACC/AHA guidelines for cardiovascular risk factor reduction|ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction]] | ||
'''[[Chronic stable angina pharmacotherapy overview|Pharmacotherapy]]:''' | |||
*'''Antiplatelet agents:''' [[Chronic stable angina treatment aspirin|Aspirin]] | [[Chronic stable angina treatment dipyridamole|Dipyridamole]] | [[Chronic stable angina treatment clopidogrel|Clopidogrel]] | *'''Antiplatelet agents:''' [[Chronic stable angina treatment aspirin|Aspirin]] | [[Chronic stable angina treatment dipyridamole|Dipyridamole]] | [[Chronic stable angina treatment clopidogrel|Clopidogrel]] | ||
| Line 59: | Line 57: | ||
*[[Chronic stable angina ACC/AHA guidelines for pharmacotherapy to prevent MI, death and reduce symptoms|ACC/AHA Guidelines for Pharmacotherapy to prevent MI, Death and Reduce symptoms]] | *[[Chronic stable angina ACC/AHA guidelines for pharmacotherapy to prevent MI, death and reduce symptoms|ACC/AHA Guidelines for Pharmacotherapy to prevent MI, Death and Reduce symptoms]] | ||
'''[[Chronic stable angina revascularization|Revascularization]]:''' [[Chronic stable angina revascularization percutaneous coronary intervention(PCI)|PCI]] | [[Chronic stable angina revascularization coronary artery bypass grafting(CABG)|CABG]] | [[Chronic stable angina percutaneous coronary intervention versus coronary artery bypass grafting|PCI vs CABG]] | [[Chronic stable angina ACC/AHA guidelines for revascularization|ACC/AHA Guidelines for Revascularization]] | |||
'''Alternative therapies for refractory angina:''' [[Chronic stable angina transmyocardial revascularization(TMR)|Transmyocardial Revascularization]] | [[Chronic stable angina spinal cord stimulation(SCS)|Spinal Cord Stimulation]] | [[Chronic stable angina enhanced external counter pulsation(EECP)|Enhanced External Counter Pulsation (EECP)]] | [[Chronic stable angina ACC/AHA guidelines for alternative therapies in patients with refractory angina|ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina]] | '''[[Chronic stable angina alternative therapies for refractory angina|Alternative therapies for refractory angina]]:''' [[Chronic stable angina transmyocardial revascularization(TMR)|Transmyocardial Revascularization]] | [[Chronic stable angina spinal cord stimulation(SCS)|Spinal Cord Stimulation]] | [[Chronic stable angina enhanced external counter pulsation(EECP)|Enhanced External Counter Pulsation (EECP)]] | [[Chronic stable angina ACC/AHA guidelines for alternative therapies in patients with refractory angina|ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina]] | ||
==Discharge Care== | ==Discharge Care== | ||
| Line 67: | Line 65: | ||
==[[Chronic stable angina secondary prevention|Secondary Prevention]]== | ==[[Chronic stable angina secondary prevention|Secondary Prevention]]== | ||
==Guidelines for Asymptomatic Patients== | |||
[[Chronic stable angina risk stratification in asymptomatic patients by noninvasive testing|Noninvasive Testing in Asymptomatic Patients]] | [[Chronic stable angina risk stratification in asymptomatic patients by coronary angiography|Coronary Angiography in Asymptomatic Patients]] | [[Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients|Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients]] | [[Chronic stable angina revascularization with PCI and CABG in asymptomatic patients|Revascularization with PCI and CABG in Asymptomatic patients]] | |||
==Landmark Trials== | ==Landmark Trials== | ||
Revision as of 17:02, 20 July 2011
| Chronic stable angina | |
| ICD-10 | I20 |
|---|---|
| ICD-9 | 413 |
| DiseasesDB | 8695 |
| eMedicine | med/133 |
| MeSH | D000787 |
|
Chronic stable angina Microchapters | ||
|
Classification | ||
|---|---|---|
| ||
| ||
|
Differentiating Chronic Stable Angina from Acute Coronary Syndromes | ||
|
Diagnosis | ||
|
Alternative Therapies for Refractory Angina | ||
|
Discharge Care | ||
|
Guidelines for Asymptomatic Patients | ||
|
Case Studies | ||
|
Chronic stable angina On the Web | ||
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Vijay Kunadian, M.D., Ph.D.; Smita Kohli, M.D.
Overview
Historical Perspective
Classification Scheme
Classic: Chronic stable angina
Atypical: Walk through angina | Mixed angina | Nocturnal angina | Postprandial angina | Syndrome X | Vasospastic angina
Differentiating chronic stable angina from acute coronary syndromes
Pathophysiology
Epidemiology and Demographics
Risk Stratification and Prognosis
Overview | ECG/Chest X-Ray | Rest LV Function | Exercise Testing | Stress imaging in patients who are able to exercise | Stress imaging in patients who are unable to exercise | Coronary Angiography
Pretest probability of CAD in the patient with angina
Diagnosis
History and Symptoms | Physical Examination | Test selection guideline for the individual basis | Laboratory Tests | Electrocardiography | Exercise ECG | Chest x-ray | Myocardial Perfusion Scintigraphy with Pharmacologic Stress | Myocardial Perfusion Scintigraphy with Thallium | Echocardiography | Exercise Echocardiography | Positron Emission Tomography | Ambulatory ST Segment Monitoring | Electron Beam Tomography | Cardiac Magnetic Resonance Imaging | Coronary Angiography
Treatment
Risk factor modifications: Smoking cessation | Weight management | Physical activity | Lipid management | BP control | Diabetes control | ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction
- Antiplatelet agents: Aspirin | Dipyridamole | Clopidogrel
- Antianginal agents: Nitrates | Beta Blockers | Calcium Channel Blockers | Newer Anti-anginal Agents
Revascularization: PCI | CABG | PCI vs CABG | ACC/AHA Guidelines for Revascularization
Alternative therapies for refractory angina: Transmyocardial Revascularization | Spinal Cord Stimulation | Enhanced External Counter Pulsation (EECP) | ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina
Discharge Care
Patient Follow-Up | Rehabilitation
Secondary Prevention
Guidelines for Asymptomatic Patients
Noninvasive Testing in Asymptomatic Patients | Coronary Angiography in Asymptomatic Patients | Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients | Revascularization with PCI and CABG in Asymptomatic patients
Landmark Trials
- COURAGE
- FREEDOM
See Also
This article is about chest pain due to oxygen shortage in the heart. For other uses of the term angina such as abdominal angina, Ludwig's angina, Prinzmetal's angina, Vincent's angina, or angina tonsillaris, click here.